期刊文献+

Bridging the structure gap between pellets in artificial dissolution media and in gastro-intestinal tract in rats 被引量:1

原文传递
导出
摘要 Changes in structure of oral solid dosage forms(OSDF) elementally determine the drug release and its therapeutic effects.In this research,synchrotron radiation X-ray micro-computed tomography was utilized to visualize the 3 D structure of enteric coated pellets recovered from the gastrointestinal tract of rats.The structures of pellets in solid state and in vitro compendium media were measured.Pellets in vivo underwent morphological and structural changes which differed significantly from those in vitro compendium media.Thus,optimizations of the dissolution media were performed to mimic the appropriate in vivo conditions by introducing pepsin and glass microspheres in media.The sphericity,pellet volume,pore volume and porosity of the in vivo esomeprazole magnesium pellets in stomach for2 h were recorded 0.47,1.55 × 10^(8)μm^(3),0.44 × 10^(8)μm^(3)and 27.6%,respectively.After adding pepsin and glass microspheres,the above parameters in vitro reached to 0.44,1.64 × 10^(8)μm^(3)0.38 × 10^(8)μm^(3)and 23.0%,respectively.Omeprazole magnesium pellets behaved similarly.The structural features of pellets between in vitro media and in vivo condition were bridged successfully in terms of 3 D structures to ensure better design,characterization and quality control of advanced OSDF.
出处 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2022年第1期326-338,共13页 药学学报(英文版)
基金 financial support from National Key R&D Program of China(2020YFE0201700) Major New Drugs Innovation and Development(2017ZX09101001-005,China) the National Natural Science Foundation of China(81803441,81803446 and 81773645) Youth Innovation Promotion Association CAS(2018323,China)。
  • 相关文献

参考文献2

二级参考文献32

  • 1ABDUL S, CHANDEWAR A, JAISWAL S. A flexible technology for modified-release drugs: multiple-unit pellet system (MUPS) [J]. JCotrolRel, 2010, 147(1): 2-16.
  • 2DECHESNE JP, DELATTRE L. A new enteric tablet of acetyl- salicylic acid. II. Biopharmaceutical aspects[ J]. Int J Pharm, 1987, 34(3) : 259 -262.
  • 3DEBUNNE A, VERVAET C, MANGELINGS D, et al. Compac- tion of enteric-coated pellets: influence of formulation and process parameters on tablet properties and in vivo evaluation [ J]. Eur J Pharm Sci, 2004, 22(4) : 305 -314.
  • 4DASHEVSKY A, KOLTER K, BODMEIER R. Compression of pellets coated with various aqueous polymer dispersions[J]. Int J Pharm, 2004, 279(1 -2) : 19 -26.
  • 5JOHANSSON B, WIKBERG M, ALDERBORN G. Compression behavior and compactability of microcrystalline cellulose pellets in relationship to their pore structure and mechanical properties[ J]. Int JPharm, 1995, 117(1) : 57 -73.
  • 6SCHWARTZ JB, NGUYEN NH, SCHNAARE RL. Compaction studies on beads : compaction and consolidation parameter [ J ]. Drug Dev Ind Pharm, 1994, 20(20) : 3105 -3129.
  • 7NICKLAASSON F, ALDERBORN G. Modulation of the tableting behavior of microcrystalline cellulose pellets by the incorporation of polyethylene glycol[ J]. Eur J Pharm Sci, 1999, 9( 1 ) : 57 -63.
  • 8DUKI(-OTT A, THOMMES M, REMON JP, et al. Production of pellets via extrusion-spheronisation without the incorporation of microcrystalline cellulose: a critical review [ J ]. Eur J Pharm Biopharm, 2009,71 ( 1 ) : 38 - 46.
  • 9GHANAM D, KLEINEBUDDE P. Suitability of K-carrageenan pellets for theformulation of multiparticulate tablets with modified release[J], lnt J Pharm, 2011, 409(1 -2): 9- 18.
  • 10JOHANSSON B, NICKLASSON F, ALDERBORN G. Effect of pellet size on degree of deformation and densification during com- pression and on compactability of microcrystalline cellulose pellets [J]. Int JPharm, 1998, 163(1 -2): 35 -48.

共引文献6

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部